Fludrocortisone Tablets

Quick links to important sections

Fludrocortisone Tablets

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fludrocortisone Tablets

Property Description
Active ingredient Fludrocortisone acetate
Form Tablets (oral)
Pharmacological Class Potent Mineralocorticoid (Corticosteroid)
General Purpose Hormone replacement therapy for salt/fluid balance
Origin Synthetic (9α-fluoro derivative of cortisol)

What Type of Medicine is Fludrocortisone Tablets?

Fludrocortisone Tablets is a synthetic adrenocortical steroid medicine, recognized for its classification as a powerful mineralocorticoid within the broader corticosteroid pharmacological class. This medication is an oral dosage form, specifically formulated to serve as partial replacement therapy for hormones that the body's adrenal glands cannot adequately produce. The compound's high mineralocorticoid selectivity, which is recognized for its control of electrolyte homeostasis, differentiates it from standard glucocorticoid treatments.

Fludrocortisone is a therapeutic tool for endocrine management. For instance, in individuals managing adrenal insufficiency, this medicine supplies the mineralocorticoid activity required to stabilize daily function.


Fludrocortisone: A Synthetic Derivative

The active ingredient in the tablets is Fludrocortisone acetate, a synthetic compound derived structurally from the natural hormone cortisol (hydrocortisone). This substance acts as a pro-drug and is converted within the body to the active molecule, Fludrocortisone.

The compound's structure, which includes a fluorine atom at the 9α-position, is its key differentiating feature; this modification increases its potency and duration of action compared to the natural equivalent, aldosterone. This effectiveness is characterized by a high affinity for the mineralocorticoid receptor.


What is the Primary General Purpose of Fludrocortisone?

Fludrocortisone's primary general purpose is to stabilize electrolyte balance and prevent volume depletion. It accomplishes this by signaling the kidneys to promote sodium retention (Na+ reabsorption) while concurrently increasing the excretion of potassium ions (K+ excretion).

This action helps to expand the extracellular fluid volume, which is vital for stabilizing blood pressure regulation and maintaining adequate circulation. By restoring these fundamental internal balances, the medicine counteracts the symptoms associated with salt and water loss from hormone deficiency.

Regulatory References

  1. Fludrocortisone Acetate: MedlinePlus Drug Information
  2. Fludrocortisone - eEML - Electronic Essential Medicines List

What side effects are possible with Fludrocortisone Tablets?

Possible Side Effects and Safety Information

The safety profile of Fludrocortisone Tablets is characterized by its powerful mineralocorticoid and systemic corticosteroid effects, as documented in official regulatory documents. Adverse reactions are formally classified by frequency and System Organ Class (SOC) to provide a clear understanding of the medicine’s risk profile.

Frequency-Classified Adverse Reactions

The most frequently observed effects are related to fluid and electrolyte balance:

Classification Adverse Reaction (Examples)
Very Common Hypertension (high blood pressure), Hypokalaemia (low potassium levels)
Common Oedema (fluid retention), Headache
Uncommon Cardiomegaly (enlarged heart)

Systemic and Serious Adverse Reactions

Adverse effects are documented across multiple SOC categories, including the Metabolism and Nutrition Disorders, Musculoskeletal, Endocrine, Ophthalmic, and Gastrointestinal systems. Serious reactions listed in official labeling include congestive cardiac failure, peptic ulcer (with potential for perforation or hemorrhage), and severe infections due to immunosuppression. The drug is contraindicated in individuals with systemic fungal infections.

Safety Patterns and Special Populations

Regulatory safety statements specify risks tied to duration of use. Prolonged exposure is associated with the development of Posterior Subcapsular Cataracts, Osteoporosis, and Adrenal Cortical Atrophy, which can suppress the body's natural hormone production. Official documents also note specific considerations for patient groups, including the potential for growth suppression in pediatric patients and the potentially more serious nature of common side effects in older adults.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents state that manifestations of Fludrocortisone Tablets overdosage are generally associated with excessive mineralocorticoid activity, typically occurring with chronic overexposure.

Documented Manifestations

The officially described clinical presentations include hypertension (elevated blood pressure), edema (fluid retention), and hypokalemia (low serum potassium levels). Further documented signs are an excessive increase in weight and an increase in heart size (Cardiomegaly). Muscular weakness is also noted as a potential consequence of excessive potassium loss.

Emergency Actions and Required Monitoring

Immediate medical attention is required for severe or life-threatening presentations. Seek emergency services immediately if a suspected overdose results in collapse, a seizure, trouble breathing, or the inability to be awakened. Contacting a poison control center is also officially recommended for management guidance.

For chronic overdosage, the mandated first step is discontinuation of the drug. Supportive management includes the administration of potassium supplements to correct electrolyte imbalance and may involve restriction of dietary sodium intake. For acute, large ingestions, procedures such as gastric lavage or emesis may be considered. Continuous monitoring of blood pressure and serum electrolytes is considered essential in the overdose setting. No specific antidote is documented in the official labeling.

Therapeutic Uses of Fludrocortisone Tablets

Quick Facts

  • Addison's disease: Used as partial replacement therapy for primary and secondary adrenal gland insufficiency.
  • Salt-losing adrenogenital syndrome: Assists in the management of this condition.
  • Fluid and Sodium Balance: Contributes to the body’s ability to maintain appropriate levels of sodium and water.

Fludrocortisone tablets are prescribed to help manage certain health conditions resulting from the body's inability to produce sufficient levels of specific steroid hormones.

The primary approved use is for partial replacement therapy in cases of both primary and secondary adrenocortical insufficiency, a key component of Addison’s disease. In this context, it is often administered alongside other replacement hormones to support the body’s essential regulatory processes.

Additionally, this medication is indicated for the management of salt-losing adrenogenital syndrome. In this role, Fludrocortisone assists the body in retaining sodium and water, which supports the achievement of fluid and electrolyte stability.

The therapy aims to support vital functions, including the maintenance of blood pressure and fluid balance. This partial replacement approach is a standard component of care for these specific hormonal insufficiencies.

Regulatory References

  1. NIH DailyMed guidance

Eligibility and Restrictions for Use

Official Population Eligibility for Fludrocortisone Tablets

Eligibility to use Fludrocortisone Tablets is strictly governed by regulatory classifications, defining who is allowed to use the medicine, who requires special caution, and who must not use it.

Absolute Contraindications

Fludrocortisone Tablets are contraindicated and must not be used by patients with:

  • A known or suspected hypersensitivity to fludrocortisone acetate or any formulation component.
  • An existing systemic fungal infection.

Age-Specific Eligibility

Population Regulatory Status
Adults Eligible for labeled indications (e.g., adrenocortical insufficiency).
Pediatric Safety and effectiveness are not established by the FDA; growth must be carefully monitored.
Older Adults Use requires caution due to increased frequency of decreased organ function.

Restricted or Conditional Use

Use of the medicine requires caution and close monitoring in patients with specific high-risk conditions, which may aggravate or complicate treatment. These conditions include hypertension, congestive heart failure, diabetes mellitus, peptic ulcer disease, osteoporosis, and myasthenia gravis.

Patients with hepatic impairment, renal insufficiency, or hypothyroidism must also be monitored closely due to the potential for an enhanced corticosteroid effect or fluid retention.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Fludrocortisone Tablets defines several interaction patterns, primarily categorized by pharmacodynamic and pharmacokinetic mechanisms.

Contraindicated Combinations and Restrictions

Co-administration with Live Virus Vaccines (including the Smallpox Vaccine) is formally contraindicated and should not be administered. This restriction is documented due to the potential hazard of neurological complications and a diminished antibody response.

Documented Interaction Patterns

Interaction Type Interacting Agents Official Outcome Statement
Additive Pharmacodynamic Effect Potassium-Depleting Diuretics (e.g., Furosemide, Thiazides) and Amphotericin B Results in enhanced hypokalemia (excessive potassium loss).
Hepatic Enzyme Induction Rifampin, Phenytoin, Barbiturates Causes increased metabolic clearance of the steroid, which can diminish its effect.
Altered Efficacy Antidiabetic Drugs (Insulin, Oral Agents) Leads to a diminished antidiabetic effect.
Fluid Retention Anabolic Steroids Results in an enhanced tendency toward edema.
Gastrointestinal Risk Aspirin / NSAIDs Causes an increased ulcerogenic effect.

Co-administration with Digitalis Glycosides increases the possibility of arrhythmias associated with the hypokalemia caused by Fludrocortisone. Additionally, co-administration with Oral Anticoagulants may result in a decreased prothrombin time response. An enhanced corticosteroid effect is specifically noted in patients with underlying conditions such as Hypothyroidism or Liver Cirrhosis.

Mechanism of Action

How Fludrocortisone Tablets Works

Fludrocortisone functions as a synthetic corticosteroid by acting as an agonist at two primary intracellular receptor systems, thereby influencing specific physiological responses.


Mineralocorticoid Receptor Activation

The drug's principal mechanism involves binding with high affinity to the mineralocorticoid receptor (MR), primarily within the principal cells of the renal distal tubules. This receptor-ligand complex translocates to the cell nucleus, altering gene transcription. This molecular cascade increases the synthesis and activity of ion transport proteins, notably the Epithelial Sodium Channel (ENaC), leading to increased reabsorption of sodium ions ( Na^+) and water back into the bloodstream. Concurrently, this mechanism promotes the excretion of potassium ( K^+) and hydrogen ions ( H^+), influencing the overall fluid and electrolyte volume.


Glucocorticoid Receptor Modulation

Fludrocortisone also engages the glucocorticoid receptor ( GR) with a moderate affinity. This binding modulates gene expression, affecting pathways associated with general metabolic and immune signaling. By acting on the GR, the drug influences the broad corticosteroid-sensitive cascades that affect various cellular stress-response systems.

Dosage and Administration Information

How to use Fludrocortisone Tablets

Administration Scope and Protocol

Fludrocortisone is strictly an oral medication, typically administered as a 0.1 mg tablet, intended for long-term partial replacement therapy in cases of adrenocortical insufficiency.

The standard adult regimen is generally 0.1 mg once daily, though the dosing range can vary from 0.1 mg three times a week up to 0.2 mg daily, which is determined by individual patient requirements. For conditions like salt-losing adrenogenital syndrome, the dose is also within the 0.1 mg to 0.2 mg daily range. The tablets may be taken with food or milk to aid administration.

Special Procedural Conditions and Adjustments

Parameter Instruction
Concomitant Use Required alongside a glucocorticoid (e.g., hydrocortisone) for proper replacement.
Dose Monitoring Dosage must be adjusted based on the careful monitoring of blood pressure and salt intake.
Pediatric Use Daily dose ranges from 0.05 mg to 0.1 mg for adrenal deficiency in children.
Missed Dose If a dose is missed, take it as soon as possible, but do not double the dose to compensate.

Connection to the Overall Use Protocol

The instructions define the use of Fludrocortisone as a dynamic, oral, daily protocol that requires concomitant administration with other hormone replacement therapies. The explicit requirements for continuous dosage adjustment based on hemodynamic and electrolyte status establish that its use is not a fixed quantity but a regulated procedural step to maintain fluid and sodium homeostasis.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fludrocortisone Tablets

Evidence for Use in Adrenocortical Insufficiency (Addison's Disease)

The evidence base for Fludrocortisone in primary and secondary adrenal insufficiency, including Addison's disease, has been established through historical clinical experience and authoritative consensus. Instead of relying on modern, large-scale randomized controlled trials (RCTs), which are rare due to the context of required mineralocorticoid activity, research often consists of long-term observational studies and comprehensive retrospective cohort data gathered in clinical practice.

Studies monitored important outcomes related to systemic or functional imbalance, such as the stability of serum electrolyte levels (sodium and potassium) and parameters of blood pressure and fluid volume status. When studied as part of a complete hormone replacement regimen, data show patterns related to the monitored stability of these physiological outcomes. Because the medicine provides a hormone relevant to vital body functions, ethical constraints limit the ability to conduct modern studies comparing it against a placebo. Therefore, the evidence base reflects established clinical practice and widespread scientific consensus.


Evidence for Use in Salt-Losing Adrenogenital Syndrome (CAH)

Research has explored the use of Fludrocortisone in children and infants with salt-losing adrenogenital syndrome (a form of Congenital Adrenal Hyperplasia). These studies primarily involve prospective and retrospective observational studies and studies focused on biochemical profiling in this population.

Studies monitored outcomes related to physiological imbalance, specifically the monitoring of sodium and fluid balance and the study of acute or disruptive episodes. Research also examined the measurement of specific plasma and urinary steroid profiles in relation to the medicine's use. The evidence level for this use is generally categorized as Moderate. Research is ongoing and tends to explore optimal dosage patterns, rather than exploring the fundamental question of replacement efficacy.


Overview of Research for Blood Pressure Regulation (Orthostatic Hypotension)

Research examined the use of Fludrocortisone in people with symptomatic orthostatic hypotension. Studies typically involve small, short-term Randomized Controlled Trials (RCTs) and various observational cohort studies.

Studies were observed in research examining physiological strain, specifically measuring the change in Systolic and Diastolic Blood Pressure (BP) drop after standing. Systematic reviews found that the findings were mixed and often based on modest sample sizes and limited follow-up durations. Due to the small size and short duration of the interventional research, the evidence for this specific use is often described as having low certainty.

Key Studies & References

  1. Fludrocortisone Acetate Tablets, USP - DailyMed (Official Labeling and Indication)
  2. Fludrocortisone Acetate: MedlinePlus Drug Information (Patient Information)
  3. Fludrocortisone - Electronic Essential Medicines List (EML status and use in CAH/Adrenal Insufficiency)
  4. Fludrocortisone - StatPearls (Review of use in Adrenal Insufficiency, CAH, and Orthostatic Hypotension)

Frequently Asked Questions (FAQ)

Common questions about Fludrocortisone Tablets (FAQ)


Q: What is Fludrocortisone Tablets used for besides Addison's disease?

Regulatory and clinical information indicates that Fludrocortisone is used as a hormone replacement therapy for conditions beyond Addison's disease. For example, it is used in the treatment of adrenogenital syndrome, which is a form of congenital adrenal hyperplasia. It is also clinically studied and used to help manage orthostatic hypotension, which involves low blood pressure upon standing.


Q: What is the difference between Fludrocortisone and other common steroids like Prednisone?

Official information describes Fludrocortisone as a unique type of corticosteroid primarily valued for its powerful mineralocorticoid activity. This means its main function is to regulate salt and water balance in the body. Other common steroids, such as prednisone, are typically classified as glucocorticoids, which are mainly used for their anti-inflammatory and immunosuppressive actions.


Q: Does Fludrocortisone Tablets interact with over-the-counter pain relievers like ibuprofen?

Yes, official drug labels warn about documented interactions with nonsteroidal anti-inflammatory drugs (NSAIDs), a class that includes ibuprofen. Taking Fludrocortisone alongside an NSAID can increase the risk of serious side effects in the gastrointestinal tract. These risks include bleeding and ulceration.


Q: Can Fludrocortisone Tablets be taken long-term?

Fludrocortisone is classified as a medicine intended for long-term partial replacement therapy in people who cannot naturally produce enough hormones. However, official safety information indicates that prolonged use is associated with specific risks. These risks may include conditions such as cataracts, glaucoma, and the suppression of the body's natural steroid production.


Q: Does taking Fludrocortisone Tablets mean I need more sodium in my diet?

No, Fludrocortisone is known to promote the retention of sodium in the body. Regulatory documents caution that due to this action, a dietary sodium restriction may actually be advisable to help avoid complications. These complications can include hypertension (high blood pressure) or edema (fluid retention). The necessary balance of sodium intake is determined through careful patient monitoring.


Q: Is it possible to become dependent on Fludrocortisone Tablets?

Official information notes a risk of adrenal cortical atrophy developing during prolonged therapy with corticosteroids. This atrophy refers to the suppression of the adrenal glands' natural function, which may persist after the medication is stopped. Official guidelines state that the dose must be gradually reduced when discontinuing treatment.


Q: Are there different strengths of Fludrocortisone Tablets available?

According to the official product information, Fludrocortisone Acetate Tablets are typically available in a 0.1 mg strength.


Q: Do Fludrocortisone Tablets interact with supplements like potassium or calcium?

The mechanism of Fludrocortisone causes the body to excrete potassium, which can lead to low potassium levels. Due to this effect, official information notes that potassium supplementation may be advisable for some individuals. However, the use of any supplement should always be determined through careful monitoring by a healthcare provider.


Q: Is it known whether Fludrocortisone Tablets causes problems for the liver or kidneys?

Official drug labels state that the medication should be used with caution in patients who have pre-existing hepatic (liver) or renal (kidney) impairment. This caution is due to the potential for enhanced corticosteroid effects or fluid retention in these patients. The drug is primarily processed by the liver and eliminated by the kidneys.


Q: Does research support the use of Fludrocortisone Tablets for postural orthostatic tachycardia syndrome (POTS)?

Official clinical guidelines from certain medical societies endorse the use of Fludrocortisone for treating symptoms associated with Postural Orthostatic Tachycardia Syndrome, even though this is often considered an off-label use. The use of this medicine in POTS is supported by the drug's primary action in regulating fluid and blood pressure.


Q: How quickly do people typically start to feel the effects of Fludrocortisone Tablets?

The effects of Fludrocortisone on mineralocorticoid balance are not immediate. Official guidance suggests that it may take some time, potentially two to four weeks, for the full effects of the medication to become noticeable.


Q: Do Fludrocortisone Tablets cause weight gain, and if so, why?

Yes, weight gain is listed as a potential adverse effect in regulatory safety documents. This weight change is often related to the drug's primary action, which promotes the retention of salt and water, leading to fluid retention or edema.


Q: Is it common to feel tired when taking Fludrocortisone Tablets?

Certain official information lists general discomfort and fatigue, including unusual tiredness or weakness, as potential side effects associated with the medication.


Q: Are there specific dietary restrictions to follow while using Fludrocortisone Tablets?

Official product information states that it may be necessary to restrict dietary sodium intake. This restriction may be required to prevent complications such as hypertension, edema, or weight gain due to the drug's salt-retaining effects. Any necessary changes to diet are determined by individual patient monitoring.


Q: Can Fludrocortisone Tablets cause changes in mood or anxiety?

Yes, systemic corticosteroids like Fludrocortisone are associated with psychiatric adverse reactions documented in official regulatory documents. These reactions may include mood swings, personality changes, euphoria, or severe depression.


Q: Do Fludrocortisone Tablets affect sleep patterns?

Official safety information lists sleep problems as a documented side effect associated with the use of this medication. These sleep issues can include insomnia or difficulty sleeping.


Q: Is it known if Fludrocortisone Tablets can be used during pregnancy?

Fludrocortisone is classified by the FDA as a Pregnancy Category C drug. Official labeling indicates that its use during pregnancy is advised only if clearly needed and when the potential benefit is determined to outweigh the potential risk. Furthermore, infants born to mothers receiving substantial doses should be monitored for signs of hypoadrenalism.


Q: How often do people usually need blood tests when taking Fludrocortisone Tablets?

The official product information advises that the dosage must be continually monitored and adjusted based on a patient's response and electrolyte status. Periodic checking of serum electrolyte levels is specifically advised during prolonged therapy to maintain safety and efficacy.


Q: Can Fludrocortisone Tablets be crushed, split, or chewed?

Regulatory guidance indicates that the tablet can be crushed and mixed with a small amount of soft food for patients who have difficulty swallowing pills. If crushing the tablet, it is important that the entire mixture be taken immediately to ensure the full dose is received.


Q: Do Fludrocortisone Tablets interact with alcohol?

Yes, official regulatory resources describe that alcohol-containing foods, beverages, or non-prescription medicines should be avoided while using Fludrocortisone. This precaution helps prevent potential complications related to the medication.


Q: Do Fludrocortisone Tablets need to be stopped gradually?

Yes, the withdrawal of Fludrocortisone after prolonged therapy must always be gradual. Official documents state that the dose must be tapered over a period of weeks or months to safely discontinue the medicine. Stopping the medication abruptly can lead to acute adrenal insufficiency.


Q: Does the use of Fludrocortisone Tablets require any special precautions before surgery?

Yes, regulatory documents indicate that patients on long-term therapy may require supportive corticosteroid therapy in times of stress, such as before and after major surgery, trauma, or severe illness. This is to ensure the body can cope with the increased physiological demand.


Q: Why is it important to carry information about taking Fludrocortisone Tablets?

Clinical guidelines often advise patients who are dependent on steroid therapy to carry an Emergency Steroid Card or similar medical documentation. This information is important to ensure that proper stress-dosing protocols are followed immediately during an emergency, such as an accident or trauma.


Q: What is the shelf life or typical expiration time for Fludrocortisone Tablets?

Official information about storage and stability often specifies that some formulations must be refrigerated. If stored outside of refrigeration, they may only be stable for a limited time, such as up to three months, before they must be discarded. Patients should always refer to the specific expiration date on their product label.


Q: Can Fludrocortisone Tablets affect the body's ability to heal wounds?

Official safety literature lists impaired wound healing as a potential adverse dermatologic effect associated with the use of corticosteroids. This is due to the broad effects these medicines have on various body systems.

How should Fludrocortisone Tablets be stored and disposed of?

How to Store and Dispose of Fludrocortisone Tablets

Fludrocortisone acetate tablets must be stored according to specific regulatory requirements to maintain product stability.

Storage Conditions

Storage temperature requirements vary by formulation. Some products must be stored in a refrigerator between 2 C and 8 C. Other formulations require storage at controlled room temperature between 20 C and 25 C. All formulations must be kept from freezing and protected from excessive heat.

The tablets must be stored in the original container and the container must be kept tightly closed to protect the medicine from light and moisture. Fludrocortisone tablets must always be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired fludrocortisone tablets must be disposed of according to local regulations. The medicine must not be thrown away via wastewater or household waste; instead, return unused portions to a pharmacy or authorized collection point for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Fludrocortisone Tablets found in:

A-Z Index: